| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 145, 598-609, Copyright © 1994 by American Society for Investigative Pathology
REGULAR ARTICLES |
SY Liao, C Brewer, J Zavada, J Pastorek, S Pastorekova, A Manetta, ML Berman, PJ DiSaia and EJ Stanbridge
Department of Pathology, St. Joseph Hospital, Orange, California.
A new tumor-associated antigen, MN, has been identified whose expression correlates with the tumorigenic phenotype of HeLa x fibroblast somatic cell hybrids. Because HeLa is a cell line derived from a cervical carcinoma, we investigated the diagnostic utility of MN expression in cervical neoplasia. It was found that normal cervical tissue does not express the antigen, or does so in occasional focal areas of weakly staining reserve cells. In contrast, significant immunoreactivity (immunoperoxidase staining of paraffin-embedded sections) was observed in cervical intraepithelial neoplasias, adenocarcinoma in situ, and frank carcinomas, both squamous cell and adenocarcinoma. Varying patterns of immunoreactivity were observed and were characterized as diffuse, diffuse/focal, or focal. Greater than 90% of dysplastic or malignant tissues showed immunoreactivity. An interesting observation was that normal cervical tissue associated with cervical intraepithelial neoplasias, or adenocarcinoma in situ showed a staining pattern in the reserve cells and/or normal columnar cells that approximated the level of intensity exhibited by the dysplastic tissue. These results indicate that MN antigen expression has potential utility as a biomarker of cervical neoplasms.
This article has been cited by other articles:
![]() |
B. C. Leibovich, Y. Sheinin, C. M. Lohse, R. H. Thompson, J. C. Cheville, J. Zavada, and E. D. Kwon Carbonic Anhydrase IX Is Not an Independent Predictor of Outcome for Patients With Clear Cell Renal Cell Carcinoma J. Clin. Oncol., October 20, 2007; 25(30): 4757 - 4764. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Brennan, K. Jirstrom, A. Kronblad, R. C. Millikan, G. Landberg, M. J. Duffy, L. Ryden, W. M. Gallagher, and S. L. O'Brien CA IX is an Independent Prognostic Marker in Premenopausal Breast Cancer Patients with One to Three Positive Lymph Nodes and a Putative Marker of Radiation Resistance. Clin. Cancer Res., November 1, 2006; 12(21): 6421 - 6431. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Uemura, K. Fujimoto, M. Tanaka, M. Yoshikawa, Y. Hirao, S. Uejima, K. Yoshikawa, and K. Itoh A Phase I Trial of Vaccination of CA9-Derived Peptides for HLA-A24-Positive Patients with Cytokine-Refractory Metastatic Renal Cell Carcinoma. Clin. Cancer Res., March 15, 2006; 12(6): 1768 - 1775. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Proescholdt, C. Mayer, M. Kubitza, T. Schubert, S.-Y. Liao, E. J. Stanbridge, S. Ivanov, E. H. Oldfield, A. Brawanski, and M. J. Merrill Expression of hypoxia-inducible carbonic anhydrases in brain tumors Neuro-oncol, October 1, 2005; 7(4): 465 - 475. [Abstract] [PDF] |
||||
![]() |
J Chen, C Rocken, J Hoffmann, S Kruger, U Lendeckel, A Rocco, S Pastorekova, P Malfertheiner, and M P A Ebert Expression of carbonic anhydrase 9 at the invasion front of gastric cancers Gut, July 1, 2005; 54(7): 920 - 927. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Ivanova, S-Y Liao, M I Lerman, S Ivanov, and E J Stanbridge STRA13 expression and subcellular localisation in normal and tumour tissues: implications for use as a diagnostic and differentiation marker J. Med. Genet., July 1, 2005; 42(7): 565 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hilvo, M. Rafajova, S. Pastorekova, J. Pastorek, and S. Parkkila Expression of Carbonic Anhydrase IX in Mouse Tissues J. Histochem. Cytochem., October 1, 2004; 52(10): 1313 - 1322. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Kim, D. Seligson, X. Liu, N. Janzen, M. H. T. Bui, H. Yu, T. Shi, R. A. Figlin, S. Horvath, and A. S. Belldegrun Using Protein Expressions to Predict Survival in Clear Cell Renal Carcinoma Clin. Cancer Res., August 15, 2004; 10(16): 5464 - 5471. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Maseide, R. A. Kandel, R. S. Bell, C. N. Catton, B. O'Sullivan, J. S. Wunder, M. Pintilie, D. Hedley, and R. P. Hill Carbonic Anhydrase IX as a Marker for Poor Prognosis in Soft Tissue Sarcoma Clin. Cancer Res., July 1, 2004; 10(13): 4464 - 4471. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. T. Bui, D. Seligson, K.-r. Han, A. J. Pantuck, F. J. Dorey, Y. Huang, S. Horvath, B. C. Leibovich, S. Chopra, S.-Y. Liao, et al. Carbonic Anhydrase IX Is an Independent Predictor of Survival in Advanced Renal Clear Cell Carcinoma: Implications for Prognosis and Therapy Clin. Cancer Res., February 1, 2003; 9(2): 802 - 811. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Murphy, M Ring, A G Killalea, V Uhlmann, M O'Donovan, F Mulcahy, M Turner, E McGuinness, M Griffin, C Martin, et al. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrepTM smears J. Clin. Pathol., January 1, 2003; 56(1): 56 - 63. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Olive, C. Aquino-Parsons, S. H. MacPhail, S.-Y. Liao, J. A. Raleigh, M. I. Lerman, and E. J. Stanbridge Carbonic Anhydrase 9 as an Endogenous Marker for Hypoxic Cells in Cervical Cancer Cancer Res., December 1, 2001; 61(24): 8924 - 8929. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Giatromanolaki, M. I. Koukourakis, E. Sivridis, J. Pastorek, C. C. Wykoff, K. C. Gatter, and A. L. Harris Expression of Hypoxia-inducible Carbonic Anhydrase-9 Relates to Angiogenic Pathways and Independently to Poor Outcome in Non-Small Cell Lung Cancer Cancer Res., November 1, 2001; 61(21): 7992 - 7998. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Karhumaa, K. Kaunisto, S. Parkkila, A. Waheed, S. Pastorekova, J. Pastorek, W. S. Sly, and H. Rajaniemi Expression of the transmembrane carbonic anhydrases, CA IX and CA XII, in the human male excurrent ducts Mol. Hum. Reprod., July 1, 2001; 7(7): 611 - 616. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ivanov, S.-Y. Liao, A. Ivanova, A. Danilkovitch-Miagkova, N. Tarasova, G. Weirich, M. J. Merrill, M. A. Proescholdt, E. H. Oldfield, J. Lee, et al. Expression of Hypoxia-Inducible Cell-Surface Transmembrane Carbonic Anhydrases in Human Cancer Am. J. Pathol., March 1, 2001; 158(3): 905 - 919. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Rosen, C. Suarez, V. L. Schuster, and L. P. Brion Expression of carbonic anhydrase IV in mouse placenta Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2001; 280(2): R365 - R375. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Li, K. Passebosc-Faure, C. Lambert, A. Gentil-Perret, F. Blanc, E. Oosterwijk, J.-F. Mosnier, C. Genin, and J. Tostain The Expression of G250/MN/CA9 Antigen by Flow Cytometry: Its Possible Implication for Detection of Micrometastatic Renal Cancer Cells Clin. Cancer Res., January 1, 2001; 7(1): 89 - 92. [Abstract] [Full Text] |
||||
![]() |
P. Karhumaa, S. Parkkila, A. Waheed, A.-K. Parkkila, K. Kaunisto, P. W. Tucker, C.-J. Huang, W. S. Sly, and H. Rajaniemi Nuclear NonO/p54nrb Protein Is a Nonclassical Carbonic Anhydrase J. Biol. Chem., May 19, 2000; 275(21): 16044 - 16049. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Karhumaa, S. Parkkila, O. Tureci, A. Waheed, J.H. Grubb, G. Shah, A.-K. Parkkila, K. Kaunisto, J. Tapanainen, W.S. Sly, et al. Identification of carbonic anhydrase XII as the membrane isozyme expressed in the normal human endometrial epithelium Mol. Hum. Reprod., January 1, 2000; 6(1): 68 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kaluz, M. Kaluzova, R. Opavsky, S. Pastorekova, A. Gibadulinova, F. Dequiedt, R. Kettmann, and J. Pastorek Transcriptional Regulation of the MN/CA 9 Gene Coding for the Tumor-associated Carbonic Anhydrase IX. IDENTIFICATION AND CHARACTERIZATION OF A PROXIMAL SILENCER ELEMENT J. Biol. Chem., November 12, 1999; 274(46): 32588 - 32595. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Ivanov, I. Kuzmin, M.-H. Wei, S. Pack, L. Geil, B. E. Johnson, E. J. Stanbridge, and M. I. Lerman Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes PNAS, October 13, 1998; 95(21): 12596 - 12601. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nogradi The Role of Carbonic Anhydrases in Tumors Am. J. Pathol., July 1, 1998; 153(1): 1 - 4. [Full Text] [PDF] |
||||
![]() |
J. Saarnio, S. Parkkila, A.-K. Parkkila, K. Haukipuro, S. Pastorekova, J. Pastorek, M. I. Kairaluoma, and T. J. Karttunen Immunohistochemical Study of Colorectal Tumors for Expression of a Novel Transmembrane Carbonic Anhydrase, MN/CA IX, with Potential Value as a Marker of Cell Proliferation Am. J. Pathol., July 1, 1998; 153(1): 279 - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Tureci, U. Sahin, E. Vollmar, S. Siemer, E. Gottert, G. Seitz, A.-K. Parkkila, G. N. Shah, J. H. Grubb, M. Pfreundschuh, et al. Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers PNAS, June 23, 1998; 95(13): 7608 - 7613. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Saarnio, S. Parkkila, A.-K. Parkkila, A. Waheed, M. C. Casey, X. Y. Zhou, S. Pastoreková, J. Pastorek, T. Karttunen, K. Haukipuro, et al. Immunohistochemistry of Carbonic Anhydrase Isozyme IX (MN/CA IX) in Human Gut Reveals Polarized Expression in the Epithelial Cells with the Highest Proliferative Capacity J. Histochem. Cytochem., April 1, 1998; 46(4): 497 - 504. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |